Dermapharm Holding SE
DMPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $172 | $163 | $115 | $121 |
| Short-Term Investments | $0 | $3 | $3 | $1 |
| Receivables | $154 | $118 | $129 | $105 |
| Inventory | $399 | $350 | $351 | $340 |
| Other Curr. Assets | $31 | $29 | $32 | $27 |
| Total Curr. Assets | $755 | $663 | $630 | $593 |
| Property Plant & Equip (Net) | $367 | $315 | $316 | $315 |
| Goodwill | $676 | $576 | $576 | $576 |
| Intangibles | $574 | $497 | $504 | $512 |
| Long-Term Investments | $112 | $100 | $21 | $82 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | -$15 | $63 | $1 |
| Total NC Assets | $1,729 | $1,473 | $1,481 | $1,487 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,484 | $2,136 | $2,112 | $2,080 |
| Liabilities | – | – | – | – |
| Payables | $110 | $101 | $98 | $95 |
| Short-Term Debt | $91 | $85 | $80 | $90 |
| Tax Payable | $0 | $35 | $37 | $67 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $142 | $140 | $93 | $75 |
| Total Curr. Liab. | $343 | $360 | $307 | $327 |
| LT Debt | $1,095 | $925 | $0 | $890 |
| Deferred Rev, NC | $0 | $0 | $0 | $11 |
| Deferred Tax Liab, NC | $129 | $110 | $112 | $112 |
| Other NC Liab. | $159 | $134 | $1,051 | $132 |
| Total NC Liab. | $1,382 | $1,170 | $1,163 | $1,145 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $20 | $0 | $17 |
| Total Liabilities | $1,726 | $1,530 | $1,470 | $1,472 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $63 | $54 | $54 | $54 |
| Retained Earnings | $562 | $438 | $467 | $433 |
| AOCI | $18 | $0 | $0 | $0 |
| Other Equity | $118 | $117 | $118 | $117 |
| Total Equity | $762 | $608 | $639 | $604 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$3 | -$3 | $4 | $4 |
| Total Liab. & Tot. Equity | $2,484 | $2,136 | $2,112 | $2,080 |
| Net Debt | $1,014 | $847 | -$36 | $858 |